Table 1.

Sample Description

At Inclusion		N	%a
Sex	Male	130	76.92
Age (median, min-max)		130	37.18 (19–59)
Age at 1st hospitalization (median, min-max)		125	22.85 (15–57)
Duration of illness (median, min-max)		128	14.13 (0–41)
Study center	Marseille	31	23.85
	Nice	20	15.38
	Montpellier	79	60.77
Educational level	Higher education	130	21.54
Marital status	Single	130	91.54
Live alone	Yes	130	46.92
Hospitalization	In-patient	130	53.85
Current smoker	Yes	130	67.69
Substance abuse or dependence	Yes	129	49.61
Daily chlorpromazine equivalent (CPZeq) drug dosage (mg/d) (median, min-max)		111	612.5 (0–4250)
Body mass index	Normal	60	46.88
	Overweight	40	31.25
	Obesity	28	21.88
At the 1-month follow-up
Depression (Calgary score)	≥6	130	23.08
PANSS scores (median, min-max)
Total score		130	66 (37–106)
Positive symptoms		130	13 (7–31)
Negative symptoms		130	18 (8–35)
General psychopathology		130	34 (19–52)
LARS apathy scores (median, min-max)
Total apathy		130	−19 (−33 to 5)
Novelty and social life (NSL)		130	−5 (−8 to 5)
Behavioral involvement (BI)		130	−4 (−8 to 6)
Emotional involvement (ER)		130	−2 (−3 to 3)
Judgment skills (JS)		130	−4 (−6 to 3)
Apathy classification (Yazbek26)
	None [−36; −24]	31	23.85
	Mild [−23; −19]	40	30.77
	Moderate [−18; −13]	30	23.08
	Severe [−12; +36]	29	22.31
Cognitive tests (median, min-max)
MSET		114	4 (1–6)
CVLT: List A Trial 1		111	6 (0–14)
TMT B-A		109	60 (14–215)
LNS		111	32 (6–37)
SSP		100	70 (20–100)

Note: MSET, Modified Six Element Test; CVLT, California Verbal Learning Test; TMT, Trail Making Test; LNS, Letter-Number Sequencing subtest; SSP, Stop Signal Paradigm; PANSS, Positive and the Negative Syndrome Scale; LARS, Lille Apathy Rating Scale.

^aOr median (min max) when specified.